News
All our News
2021-09-01
CANCEL CANCER-campaign

A world without childhood cancer - without side effects, without late effects. This is our vision.
2021-08-27
Award-worthy: brain tumor research by AG Schüller honored

Brain tumors make up the second most common childhood cancers after leukemias, and some tumor types are still associated with a very poor prognosis.
2021-07-12
Immune cells: biomarkers in childhood brain tumors.

The infiltration of tumor infiltrating lymphocytes (TILS) into a tumor allows statements on the immune response as well as prognoses on therapy success and survival outcomes.
2021-07-07
Research report 2021

The Research Institute Children's Cancer Center Hamburg was founded 15 years ago with the goal of better understanding the molecular basis of childhood cancer development and paving the way for new therapies. Today, around 50 employees, physicians, scientists and technical assistants work in the field of stem cell transplantation and immunotherapy, leukemias as well as […]
2021-05-19
Please apply now

Juli-Harnack-scholarship for medical postgraduate students in the field of pediatric onkology
2021-04-15
ZNF423 - the underrated player in leukemogenesis?

New insights into the development of ALL - the most common type of cancer in childhood.
2020-12-21
New knowledge in pediatric brain tumor research

Clinically and molecularly distinct subgroup discovered within the group of atypical teratoid / rhabdoid tumors
2020-12-01
Official supporter of the „Nationale Dekade gegen Krebs"

Research institute becomes part of the national cancer initiative of the BmBF / BmfG
2020-11-13
DER SCHMETTERLING - focus on brain tumors in children. So much to be done...

What are the special challenges in the area of research, therapy and long-term effects? What does the diagnosis mean for affected families? In the current readout of the member magazine DER SCHMETTERLING, the Fördergemeinschaft Kinderkrebs-Zentrum Hamburg e.V. . presents our current research in the field of child brain tumors. The new edition is available for download.
2020-10-21
Medulloblastoma research in Hamburg: new therapeutic approach for especially young brain tumor patients

Medulloblastoma is the most common malignant brain tumor in early childhood. Due to its genetic diversity, the course of the disease and the chance of recovery are very different. The treatment of medulloblastoma is often difficult - also because there is a lack of knowledge about tumor formation and development. The children who survive will […]
2020-09-07
Space and time for science. New clinician scientist for brain tumor research

Once a year, the UCCH Research Retreat is probably the most popular opportunity for all Hamburg cancer researchers to get to know each other and exchange ideas. Even though the meeting was held virtually this time, there were, in addition to substantial talks, poster presentations, and young research prizes, again four grants, which give young […]